PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical OncologyFederica Miglietta, Stefania Gori, Michela Cinquini et al.|The Breast|2022Cited by 16
Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical OncologyPaola Queirolo, Francesco Spagnolo, Roberto Patuzzo et al.|ESMO Open|2023Cited by 16
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical OncologyPaola Queirolo, Francesco Spagnolo, Michela Cinquini et al.|ESMO Open|2024Cited by 15
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus projectStefania Gori, Paolo Tralongo, Fiorenza De Rose et al.|Cancer Treatment Reviews|2024Cited by 2
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectivesStefania Gori, Riccardo Gerosa, Michela Cinquini et al.|Tumori Journal|2025Cited by 1